Palmar plantar erythrodysesthesia risk factors: Difference between revisions
Mchitsazan (talk | contribs) |
Mchitsazan (talk | contribs) |
||
| Line 1: | Line 1: | ||
'''Editor-In-Chief:''' [[User:C Michael Gibson|C. Michael Gibson, M.S., M.D.]], '''Associate Editor(s)-in-Chief:''' | '''Editor-In-Chief:''' [[User:C Michael Gibson|C. Michael Gibson, M.S., M.D.]], '''Associate Editor(s)-in-Chief:''' [[Mandana Chitsazan, M.D.]] | ||
{{Palmar plantar erythrodysesthesia}} | {{Palmar plantar erythrodysesthesia}} | ||
| Line 5: | Line 5: | ||
__NOTOC__ | __NOTOC__ | ||
==Overview== | ==Overview== | ||
The most common and established risk factors are chemotherapeutic agents. The severity of the condition depends on the dose and frequency of the agent. | |||
The most common and established risk factors are chemotherapeutic agents. The severity of the condition depends on the dose and frequency of the agent | |||
==Risk Factors== | ==Risk Factors== | ||
Exposure to chemotherapeutic agents has been proven to be an established risk factor. Occurrence of this condition has been linked to dose and prolonged chemotherapeutic drug exposure | Exposure to chemotherapeutic agents has been proven to be an established risk factor. Occurrence of this condition has been linked to dose and prolonged chemotherapeutic drug exposure. The data is limited to support any other associated risk factors as the pathophysiology of palmar plantar erythrodysesthesia. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 14:18, 2 July 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D., Associate Editor(s)-in-Chief: Mandana Chitsazan, M.D.
|
Palmar plantar erythrodysesthesia Microchapters |
|
Differentiating Palmar plantar erythrodysesthesia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Palmar plantar erythrodysesthesia risk factors On the Web |
|
American Roentgen Ray Society Images of Palmar plantar erythrodysesthesia risk factors |
|
Directions to Hospitals Treating Palmar plantar erythrodysesthesia |
|
Risk calculators and risk factors for Palmar plantar erythrodysesthesia risk factors |
Overview
The most common and established risk factors are chemotherapeutic agents. The severity of the condition depends on the dose and frequency of the agent.
Risk Factors
Exposure to chemotherapeutic agents has been proven to be an established risk factor. Occurrence of this condition has been linked to dose and prolonged chemotherapeutic drug exposure. The data is limited to support any other associated risk factors as the pathophysiology of palmar plantar erythrodysesthesia.